ArticleOncotarget2015

OSI-027 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine both in vitro and in vivo.

Xiao Zhi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.